ReNeuron Group ^Public

ReNeuron Group is a leading stem cell technology company that focuses on the research, development, and commercialization of stem cell therapies for both therapeutic and non-therapeutic applications. Their proprietary stem cell-based exosome technologies have shown promising results in various in vivo studies. The company is listed on the London Stock Exchange and has recently presented their in vivo data at the prestigious Cell 2023 conference. ReNeuron Group is committed to advancing the field of regenerative medicine and improving patient outcomes through innovative stem cell therapies.